Nazem Akoum, MD, MS, FACC, FHRS Associate Professor of Medicine

Slides:



Advertisements
Similar presentations
Managing anticoagulation in atrial fibrillation Dr Katy Rice June 2011.
Advertisements

AF and the New Oral Anti-Coagulants
Stratifying stroke risk to guide antithrombotic therapy in patients with AF.
Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Fonarow GC et al. J Am Coll Cardiol 2007; 49(19):
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
Peking University Dayi Hu Sept 16, IHF,Beijing, 2005 Atrial Fibrillation in China.
Overview of Adult Cardiovascular Disease Social Security Administration Compassionate Allowances Outreach Hearing on Cardiovascular Disease and Multiple.
AF and NOACs An UPDATE JULY 2014
Understanding Risk Professor Dan Atar, MD, FESC Dept. of Cardiology
The GARFIELD Registry is funded by an unrestricted research grant from Bayer Pharma AG Case discussion The patient caught between.
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
Multiple risk factors raise ischaemic stroke risk comparable to AF in the elderly: A large Chinese insurance analysis from 425,600 Chinese individuals.
Quartiles of complete blood count components Jeffrey L. Anderson, et al. Am J Cardiol 2007;99:
M. JESSUP Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010.
Aspirin Resistance: Significance, Detection and Clinical Management of This Real Phenomenon Webcast May 10 th, 2004 Sponsored by.
Atrial Fibrillation and Cryptogenic Stroke: Is There a Link?
Presented by Renato D. Lopes, MD, PhD, Duke Clinical Research Institute, Duke University, USA for the ARISTOTLE investigators. Efficacy and Safety of Apixaban.
CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease.
CHADS, SHMADS: What’s All This About Anticoagulation? COPYRIGHT © 2016, ALL RIGHTS RESERVED From the Publishers of.
Rhythm and Rate Control for Atrial Fibrillation Tom Wallace, MD Cardiac Electrophysiology CHI St. Vincent Heart Clinic Arkansas.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Why Treat Patent Forman Ovale Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. Benefit of Anticoagulation Unlikely in Patients With Atrial.
Location of Thrombus in Non-Rheumatic Atrial Fibrillation SettingNAppendage(%) LA Body (%)Ref. TEE (21%) 1 (0.3%) Stoddard; JACC ’95 TEE233.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Does the Left Atrial Appendage Morphology Correlate.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Epidemiology and natural history of atrial fibrillation:
Digoxin And Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter? Renato D. Lopes, MD,
Postulated Association Between AF and Stroke
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
for Overall Prognosis Workshop Cochrane Colloquium, Seoul
Epidemiology and burden of atrial fibrillation and associated stroke
Disclosure Statement of Financial Interest
Atrial Fibrillation and Obstructive Sleep Apnea
Identifying patients with atrial fibrillation and "truly low" thromboembolic risk who are poorly characterized by CHA2DS2-VASc: Superior performance of.
Exploring Factors Associated with Preferential Prescribing of Apixaban Over Warfarin in Patients with Non-Valvular Atrial Fibrillation Scott McColgana,
How Do We Incorporate Patient Perspectives Into Clinical Trial Design?
A Comparison of RE-LY and ROCKET AF Trial Designs and Outcomes
No evidence that AF type significantly impacts stroke risk
AMIA Joint Summits 2017 San Francisco
Circ Cardiovasc Qual Outcomes
Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.
Role of the CHADS2 Score in Acute Coronary Syndromes
CHADS2 Score Predicts Postoperative Atrial Fibrillation in Patients Undergoing Elective Pulmonary Lobectomy  Svetlana Kotova, MD, Mansen Wang, PhD, Katie.
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control 
Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation  Lena Rivard, MD, MSc, Paul Khairy, MD,
Digoxin And Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter? Renato D. Lopes, MD,
A. Epidemiology update:
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.
CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation  Walid Saliba, MD, MPH, Gad Rennert,
A. Epidemiology update:
Presenter: Wen-Ching Lan Date: 2018/10/17
Identifying High-Risk AF Patients
Development of a risk of stroke score in the Lebanese population
Predicting New-Onset Post-Coronary Artery Bypass Graft Atrial Fibrillation With Existing Risk Scores  Benjamin D. Pollock, PhD, MSPH, Giovanni Filardo,
AMYLOID AND AF: WHAT ARE WE MISSING?
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in patients with atrial fibrillation: the Swedish Atrial Fibrillation.
Optimizing Atrial Fibrillation Management
Predicting atrial fibrillation ablation outcome: The CAAP-AF score
Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey  Maura Marcucci, MD, Gregory Y.H. Lip,
Björn Redfors et al. JACEP 2017;j.jacep
Volume 10, Issue 9, Pages (September 2013)
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
Figure 1 Novel markers of increased stroke risk in AF
Figure 8. Stroke prevention strategy in patients with AF
Figure 1. Decision-making process of stroke prevention in patients with AF from Asia. The decision-making process includes stroke risk evaluation, OAC.
Atrial Fibrillation: An Escalating Cardiovascular Disease With Significant Clinical and Economic Consequences.
The CHA(2)DS2-(VASc) stroke risk and HAS-BLED bleeding risk index are calculated by totalling the scores for each risk factor present.68–71 The lower graph.
Presentation transcript:

CHA2DS2-VASC vs Atrial Fibrosis for Predicting Stroke in the AF patient Nazem Akoum, MD, MS, FACC, FHRS Associate Professor of Medicine Director, Atrial Fibrillation Program University of Washington Seattle, WA @nazemakoum

Stroke and Atrial Fibrillation AF is associated with a 5-fold  in risk of stroke1 15-25 % of strokes in the US are attributable to AF1 Severity (and mortality) of stroke with AF is worse than without AF 3 Real number may be higher as some cryptogenic strokes are also suspected to be due to AF In 20-45% of those, AF is first diagnosed at the time of the stroke 1. Fuster V, et al. J Am Coll Cardiol. 2001;38:1232-1239. 2. Benjamin EJ, et al. Circulation. 1998;98:946-952. 3. Dulli A. et al. Neuroepidemiology. 2003;22:118-123. 4. Page RL et al. Circulation. 2003;107:1141-1145.

Embolic Stroke

Thrombo-embolism Risk Assessment Risk Category Risk Score AF Investigators NICE SPAF ACC/AHA/ESC ACCP CHADS2 CHA2DS2-VASc Content Slide Layout: TEXT Framingham CHADS2-revised

CHA2DS2-VASc CHF Hypertension Age Diabetes Stroke Vascular Disease 1 point for either clinical HF or LVEF <40% CHF 1 point Hypertension 1 point if 65-75 2 points if ≥75 Age Diabetes 2 points for prior stroke or TIA Stroke 1 point for coronary or peripheral vascular disease Vascular Disease 1 point if female Sex Category Total possible points = 9

Risk Assessment Tools Ease of Use Accuracy CHADS2 WA2S3DScR2 AFI CHA2DS2VASc AFI CHADS2 WA2S3DScR2

Stroke or Thrombo-embolism CHA2DS2-VASc

Receiver Operating Characteristic (ROC) curves

Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Fang et al, J Am Col Cardiol 2008 Aakre C et al Stroke2014

CHA2DS2-VASc scores for prediction of stroke Discrimination performance of CHADS2 and CHA2DS2-VASc scores for prediction of stroke or transient ischaemic attack (TIA). Receiver operator characteristic curves for the performance of CHADS2 (A) and CHA2DS2-VASc (B) scores in predicting incident stroke or TIA. L Brent Mitchell et al. Heart 2014;100:1524-1530

How to improve the predictive accuracy of CHA2DS2-VASc? Why does it perform poorly? Populations studied Specificity of component risk factors to AF related stroke Additional risk factors not included Mechanistic relationship to stroke, AF or both

Overall stroke rate in atrial fibrillation cohorts in order of descending stroke rate (events per 100 person-years). Overall stroke rate in atrial fibrillation cohorts in order of descending stroke rate (events per 100 person-years)‏ Gene R. Quinn et al. Circulation. 2017;135:208-219

CHA2DS2-VASc scores for prediction of stroke Discrimination performance of CHADS2 and CHA2DS2-VASc scores for prediction of stroke or transient ischaemic attack (TIA). Receiver operator characteristic curves for the performance of CHADS2 (A) and CHA2DS2-VASc (B) scores in predicting incident stroke or TIA. L Brent Mitchell et al. Heart 2014;100:1524-1530

Not Comprehensive Enough? Prior Stroke/TIA Age DM CHF Vascular disease Sex Kidney Disease Paroxysmal/Persistent Race/Ethnicity Family Hx/Genetics of Stroke Biomarkers

Goette, A Europace 2016

Biomarkers, AF and stroke Cushman, Stroke 2014

Troponin I NT-proBNP

Atrial Cardiomyopathy Goette, A Europace 2016

LGE-MRI of the left atrium

Image Processing: Segmentation and Quantification Quantification of left atrial fibrosis using LGE-MRI and image processing Oakes, Kholmovski, Marrouche et al. Circulation 2009 Apr 7;119(13):1758-67

LA LGE Correlates with Fibrosis in Human Tissue Samples 3D LGE-MRI image Masson’s trichome Myocytes (red) Collagen (blue) McGann, Wilson, Marrouche et al. Circ Arrhythm Electrophysiol 2014;7(1):23-30

LA Fibrosis and Ablation Success McGann et al. Circ Arrhythm Electrophysiol 2014;7:23-30

Left Atrial Sphericity Bisbal F, et al, JCE 2013

Atrial Fibrosis and Contractile Function Kuppahally S, Akoum N, et al Circ Cardiovasc Imag 2010

MRI fibrosis and history of stroke p<0.001 Stroke Prevalence (%) Quartile 1 (<8.5%) n=97 Quartile 2 (8.6-16%) n=97 Quartile 3 (16.1-21%) n=97 Quartile 4 (>21%) n=96 Daccarett et al J Am Coll Cardiol. 2011 Feb 15;57(7):831-8.

Trans-esophageal Echocardiography

Atrial Fibrosis and Thrombus Akoum et al, JCE 2013

LA Fibrosis and Risk of Stroke 1,223 patients King J et al. JACC 2017. 70 (11):1311-21

Predictive accuracy ROC analysis Model including CHADS2VASc, AF type, INR Model including CHADS2VASc, AF type, INR and Fibrosis Stage Akoum et al, JCE 2013

How to improve CHA2DS2-VASc? Better our understanding of thrombus formation and embolization Recognizing the role of atrial disease in this process is an important step forward We need more studies in large and inclusive populations to validate this approach

Thank you!

Stroke and Atrial fibrosis